Our anti-cancer screening identified PAMAM dendrimers as promising anti-HER2 compounds with the most effect seen in G6NH2, corresponding with the general trend regarding the extent of PAMAMs activities; surface chemistry and generation-dependency. The gene discussed is ERBB2; the disease is cancer.